Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Ocrelizumab

Livnat Brill, Ariel Rechtman, Omri Zveik, Nitzan Haham, Esther Oiknine-Djian, Dana G. Wolf, Netta Levin, Catarina Raposo, Adi Vaknin-Dembinsky

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Ocrelizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences